TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 2 | -7 | -7 | 8 | 21 | 5 | -26 | -1 |
| P | %wins | 0 | 0 | 50 | 100 | 50 | 50 | 42 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
10/30/24 16:17 | 10/28/24 | MNPR | Monopar Therapeutics | DE | Health | Drug | Pharmaceutical Preparations | Radhakrishnan Karthik | IL | O | CFO | P | 25 | 16.25 | 0 | 2 | New | 2 | D | ||||||||||||||
4/9/15 17:22 | 4/8/15 | OPXA | Opexa Therapeutics, Inc. | TX | Health | Drug | Pharmaceutical Preparations | Radhakrishnan Karthik | TX | O | CFO | M.d | 0 | 0.00 | 0 | 50 | 67 | 125 | D | -74 | -71 | -47 | -32 | -33 | -24 | -9 | -2 | 0 | -16 | -22 | -12 | -16 | -32 |
12/18/13 15:55 | 12/18/13 | OPXA | Opexa Therapeutics, Inc. | TX | Health | Drug | Pharmaceutical Preparations | Radhakrishnan Karthik | TX | O | CFO | P | 14 | 1.70 | 0 | 8 | 16 | 58 | D | -56 | 34 | 25 | 11 | -9 | -10 | -7 | -2 | -11 | -9 | -2 | 2 | -13 | -57 |
8/9/13 08:00 | 8/8/13 | OPXA | Opexa Therapeutics, Inc. | TX | Health | Drug | Pharmaceutical Preparations | Radhakrishnan Karthik | TX | O | CFO | P | 75 | 1.50 | 1 | 50 | New | 50 | D | -71 | -32 | -47 | -19 | -6 | -12 | -7 | 0 | -3 | -4 | 17 | 40 | 23 | 6 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |